DVA vs EBS
DaVita HealthCare Partners Inc (DVA) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
DaVita HealthCare Partners Inc (DVA) is a medical care facilities company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported DVA revenue for 2024-12-31 was $12.82B. Net income was $1.25B. Revenue was up 5.6% from 2023-12-31 to 2024-12-31. DVA currently screens at market cap $10.77B and trailing P/E 14.1.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
DVA currently screens at market cap $10.77B and trailing P/E 14.1. EBS currently screens at market cap $416.4M.
Not investment advice. Open the DVA and EBS stock pages for the full models.
Not investment advice.